• Leasing agreements provide a combined 28,483 square feet of space
• Additional space allows company to work towards several long-term business objectives
• Company eyeing R&D, in-house manufacturing, and formation of company divisions created to support strategic expansion plans

With its focus on continued growth and innovation, TAAT(TM) Global Alternatives (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP2) recently signed lease agreements for two facilities in Las Vegas; the buildings are located in the Hughes Airport Center business park, which is conveniently located near the McCarran International Airport (https://ibn.fm/CApMM). In the announcement, TAAT noted that the agreements provide a combined 28,483 square feet of space, which the company intends to use for research and development, manufacturing, warehousing, and distribution management. The facilities will also provide office space for executives’ operational staff as well as ample room for conferences and other TAAT events. “As the company begins to scale its market presence in 2021 following the recent announcement of a CAD $149,000 purchase order intended for distribution in the United Kingdom and Ireland, as well as sustained operations in Ohio and online across the United States through e-commerce, TAAT is proactively assembling an expanded corporate infrastructure to facilitate anticipated growth,” the announcement stated. “The company believes that with these facilities at its disposal, it will be better positioned to work towards several of its long-term business objectives.” Those objectives include R&D, in-house manufacturing, a contact center and customer experience management center, as well as the formation of company divisions created to support the company’s strategic expansion plans. The new facilities provide space for internal labs dedicated to evaluating future iterations of the company’s flagship product, TAAT(TM), as well as additional products that may be developed. In addition, the 250% increase in available space will allow the company to significantly grow its manufacturing process. Currently the company produces enough material for an estimated 680,000 10-pack cartons of TAAT a year; the 250% increase in available space provides room for significant production capability growth. Other plans include establishing an internal contact center for current and prospective customers to reach out to TAAT, as well as global distribution division that would monitor distribution channels, prioritize shipment dispatching, gather market and supply chain intelligence, and work directly with warehouse personnel to optimize distribution operations. TAAT also anticipates needing office space for its growing number of employees, many working in new operational divisions that could include sales, marketing, digital content production, social media, event management and legal. The lease agreements also provide conference and meeting spaces to enable internal collaboration as well as for hosting meetings with clients, vendors, and service providers. TAAT identified the Hughes Airport Center as an ideal location for the growing company because of its close proximity to the airport, which is the eighth busiest airport in the country, as well as I-15 and I-215, which provide easy access for transport of goods. TAAT Lifestyle and Wellness has developed TAAT, a tobacco-free and nicotine-free alternative to traditional cigarettes available in Original, Smooth and Menthol varieties. TAAT’s base material is Beyond Tobacco(TM), a proprietary blend that undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. Under executive leadership with Big Tobacco pedigree, TAAT was launched first in the United States in Q4 2020 as the company seeks to position itself in the $814 billion global tobacco industry. For more information, visit the company’s websites at www.TryTAAT.com and www.TAATGlobal.com. NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at https://ibn.fm/TOBAF

• DGTL averaging a +70% revenue growth for 2021 (vs. previous FYTD)
• DGTL is seeking to build a portfolio of high growth martech software assets via M&A, targeting Social Media, Gaming, A/V Streaming and Analytics software
• Wholly owned Hashoff LLC – an enterprise-level social media influencer content management software serving global brands such as Anheuser Busch, Dunkin Brands, Syneos Health, DoorDash, Shein, Veritone, Dentsu, Publicis Groupe, etc.
• Hashoff recently signed Beam Suntory – the third-largest producer of premium distilled product brands worldwide, with 4,800 employees, large distilleries in several countries, and owner #1 selling bourbon brand in the world, Jim Beam
• Recent campaigns at the NCAA March Madness and PGA Masters for new client signing DraftKings, a global leader in digital sports entertainment and gaming
• DGTL funding Hashoff 2.0 for Tiktok, SnapChat, Youtube – ETA June of 2021

DGTL Holdings (TSX.V: DGTL) (OTCQB: DGTHF), a venture capital asset management company focused on the acquisition and acceleration of digital media, marketing technology (martech), and advertising technology (adtech) powered by artificial intelligence (“AI”), has released financial results for both the three-month and nine-month periods ending February 28, 2021, which represents the Q3 and YTD financial results for FYE 2021 (https://ibn.fm/4gxtZ). DGTL reported that ending February 28, 2021, total revenue for the three-month period reached $1,250,782, while revenue for the nine-month period was $3,666,603. The latter figure marks a 71% growth in revenue compared to the same nine-month period of 2019, when reported revenue was $2,142,484, stemming their first acquisition, Hashoff LLC. Hashoff LLC, also known as #HASHOFF, is an enterprise-level social media influencer content management software (“CMS”) solution. The focal point of #HASHOFF is global brands and leading advertising agencies. The CMS platform enables marketers to leverage the “gig” economy by identifying, scanning, optimizing, engaging, and managing over 150 million freelancer’s content to geo-target event-marketing, brand content among all languages, regions, and product categories. Commenting on Hashoff’s growth, Steven Goldberg, DGTL’s Chief Operating Officer, stated that the subsidiary has executed well during challenging market conditions. “Hashoff’s operational team has delivered revenue growth and a global brand customer base. The DGTL leadership team is pleased with Hashoff’s initial business development achievements. We look forward to continued momentum,” Goldberg added. Hashoff serves global brands in many different industries, including the CPG, health, sports entertainment, gaming, and retail sectors. DGTL reports that the subsidiary has added major new contracts since February 28, 2021, the end of the Q3 financial reporting date. One major client that Hashoff signed a new campaign activation contract with is DraftKings (NASDAQ: DKNG), a leader in the global digital sports entertainment and gaming industries (https://ibn.fm/2Rqz0). Another of these contracts is a new software service agreement between Hashoff and the third-largest producer of premium distilled brands globally, Beam Suntory. Under the agreement, Hashoff’s initial campaign for Beam Suntory will consist of video-based influencer content that showcases innovative product applications to the consumer market globally. Hashoff successfully implemented the same type of alternative digital marketing content distribution strategy in other recent campaigns for major global brands (https://ibn.fm/zLCOv). Beam Suntory owns the top-selling bourbon brand globally. It is recognized as the first to bring premium Japanese single malt brands to a global market via a $16 billion acquisition. Additionally, the company owns large-scale distilleries in Scotland, Spain, Japan, Mexico, and the United States. It has more than 4,800 employees, with headquarters in Chicago and offices in Osaka, Japan. DGTL has a vision of building a diversified portfolio of fully commercialized enterprise level digital media and martech software companies to be a full service platform for global brands. DGTL is an AI tech accelerator that grows revenue, IP and profitability of its subsidiaries via;

• Business Strategy: DGTL provides leadership in software engineering, executive management, recruitment, PR-marketing, business development, corporate services
• Capital Markets: sourcing venture capital via debt, equity, and public offerings, including financial modeling, due diligence, investor materials, capital roadshows, etc.
• Mergers and Acquisitions: DGTL’s deal desk committee and custom proprietary valuation system identifies new opportunities to acquire, fund and accelerate digital media and marketing technology companies, to build a diversified portfolio of assets
• Growth Partnerships: DGTL collaborates on CMO-level buy-side relationships with global fortune 100 level brands, as well as building new channel partnerships with leading agencies and complimentary technology accelerators and venture capital funds, to expand its base of subsidiary companies, and their customers.

To empower innovation, DGTL partners with growth-stage enterprise software companies, adding leadership, strategic planning, and valuable resources to the company’s overall portfolio. DGTL advances development while streamlining operations in a scalable and sustainable way through senior executives and an expert advisor network who provide the tools, technology, expertise, networks, and resources to maximize growth in subsidiary companies. For more information, visit the company’s website at www.DGTLInc.com. NOTE TO INVESTORS: The latest news and updates relating to DGTHF are available in the company’s newsroom at https://ibn.fm/DGTHF

• ISW Holdings announces financial performance for 2020, with telehealth reporting 69% revenue and 276% asset growth
• Company expects best yet to come with 2021 revenues at least tripling 2020 topline performance as crypto mining business starts to yield results
• ISWH looks ahead to expansion of crypto presence, uplisting on OTCQB

Despite pandemic-related challenges, 2020 was the year of dramatic transformation for ISW Holdings (OTC: ISWH), leading to much bigger expectations in 2021. The global brand management company, which has strategically invested in telehealth and cryptocurrency mining, has issued updates on 2020 financial performance and business plans for the quarters ahead (https://ibn.fm/zzBXV). Over the past two years, the company demonstrated steady growth, driven mainly by its telehealth and home healthcare division investments. ISWH believes this success is only the beginning, and the best is yet to come as this financial data predates the launch of its cryptocurrency mining and mining equipment segment. ISWH believes the revenue growth is set to continue as returns on investments in its cryptocurrency mining and mining equipment begin to reflect in 2021. More specifically, the company expects full-year 2021 revenues to at least triple 2020 topline performance (https://ibn.fm/chK1Z). Financial highlights for the year ended Dec. 31, 2020, demonstrate year-over-year gross revenues growth of 69% for the company’s telehealth joint venture, Paradigm Home Health, where ISW Holdings earns 50% of the net profit or loss. Telehealth business line provides robust and steady cash flows for the company while its mining segment gets up to full speed. With multiple orders of new miners available immediately and a batch of new ones that will be manufactured and ready to ship in August, ISWH appears poised to increase the mining capacity and capitalize on the current market environment. It appears that ISWH will not stop there as the company is building its presence in a mining project in Georgia with at least a $500–700k per month opportunity from this expansion. The current cryptocurrency market is on the upswing as investor interest in digital currencies was surging over the recent months. Crypto mining is an essential part of a cryptocurrency ecosystem as miners keep the blockchain secured and trustworthy as they validate new transactions and record them on the global ledger blockchain through millions of computers worldwide. The global mining hardware market is expected to increase by $2.8 billion during 2020–2024, growing at a CAGR of 7% during the period (https://ibn.fm/JppJJ). At the end of last year, ISWH committed to an anti-dilution initiative announcing negotiations with noteholders to protect the value of its common stock. As of this month, the company has eliminated more than $3.4 million (94%) of outstanding convertible debt, believing that this move not only removes shareholders dilution risk but also boosts its ability to attract top talent and execute on new partnership and acquisition opportunities (https://ibn.fm/Ai28P). ISW Holdings appears to have big plans for 2021. With several minor steps remaining in the process of uplisting on the OTCQB, plans are on track for its public market debut. “We are at the bottom of the hockey stick as far as growth potential, with a clean bill of health on the balance sheet and major new non-dilutive funding providing us with a strong capital foundation to continue aggressive expansion in cryptocurrency mining and mining equipment,” said ISW Holdings president and chairman Alonzo Pierce. For more information, visit the company’s website at www.ISWHoldings.com. NOTE TO INVESTORS: The latest news and updates relating to ISWH are available in the company’s newsroom at http://ibn.fm/ISWH

• StorEn Technologies Inc. delivers proprietary vanadium flow batteries offering a variety of benefits over existing lithium and lead acid batteries
• The company’s growing intellectual property portfolio currently features four international PCT patents and five trademarks
• The total investment in the company’s technology has exceeded $2 million
• StorEn secured a $500,000 order to provide 30 kWh vanadium flow batteries to a renewable hydrogen plant at Queensland University of Technology in Australia
• The global battery energy storage market is forecast to reach $19.74 billion by 2027, recording a CAGR of 20.4% from 2020 to 2027
• StorEn is led by an executive team with decades of experience in the vanadium flow battery industry, including two previous startups exited to listed buyers
• The company is currently accepting investments through a Reg A+ offering on StartEngine Campaign, where it has raised more than $6.7 million from over 5,000 investors to date

StorEn Technologies delivers proprietary vanadium flow batteries aimed at revolutionizing the world of residential and industrial energy storage. With an expected life of 25 years and more than 15,000 cycles, the company’s batteries satisfy market demand for efficient, durable and cost-effective energy storage, enabling self-consumption of self-produced electricity and the transition toward a carbon-free economy. The company is currently accepting investments through a Reg A+ offering on StartEngine. For more information, view the company’s Offering Circular. To date, StorEn has raised more than $6.7 million from over 5,000 investors on the crowdfunding platform, along with venture capital from the ANYSEED Fund. StorEn’s growing intellectual property portfolio currently features four international PCT patents and five trademarks, securing its innovative IP in all major regions and countries in the world. A Disruptive Approach to Energy Storage StorEn’s patent-pending all-vanadium flow battery technology offers a variety of benefits over existing lithium and lead acid batteries, including:

• Eco-Friendly: StorEn vanadium flow batteries are 100% recyclable, featuring a 100% reusable electrolyte and low GHGs emissions
• Safe: The company’s batteries are both non-flammable and non-explosive
• Cost Effective: StorEn’s cost/kWh is comparable to that of lithium batteries, but its cost/cycle is up to four times lower than lithium batteries, thanks to the exceptional duration of over 25 years or 15,000 cycles
• Efficient: The company’s vanadium flow battery technology offers the highest power density thanks to MULTIGRIDS(TM), +35% in energy storage capacity with the same volume and +5% round-trip efficiency in harsh climate thanks to its proprietary THERMASTABLE(TM) geothermal design. StorEn’s solution is also virtually maintenance-free, leveraging its proprietary RESAFE(TM) and EQUILEVELS(TM) technologies.

StorEn batteries are modular and configurable in either 20kWh or 30kWh versions sharing the same Power Module, ensuring that customers only pay for the energy capacity they really need. The ability to connect additional modules allows for maximum flexibility. Traction in the Market To date, the total investment in the company’s technology has exceeded $2 million, and it is already putting these efforts to work. StorEn secured a $500,000 order in Australia to provide 30 kWh StorEn vanadium flow batteries to a renewable hydrogen plant at Queensland University of Technology (QUT), where researchers will develop safety standards for the future use of vanadium flow batteries. The first battery – the first of its kind in Australia – was installed in Brisbane in November 2020 at the National Battery Testing Centre (NBTC), a flagship project of the Future Battery Industries CRC. Additional units are being manufactured. StorEn has also entered into a supply chain deal with Multicom Resources, an Australian mining company which is the owner of two vanadium mines. Through this agreement, StorEn has secured the exclusive availability of vanadium for up to 20 years with either a price cap or at market price, whichever is lower. Capitalizing on the Australian government’s support to fulfil the country’s energy storage opportunity, Multicom’s subsidiary, Freedom Energy, has agreed to assemble StorEn batteries within Australia and distribute them widely across the wider Asia Pacific region. In addition to an initial pilot plant, Multicom has completed a concept design for a full-scale manufacturing facility for StorEn batteries. Market Opportunity The shift to renewable energy sources is on, with governments around the globe discussing and implementing initiatives to reduce dependence on fossil fuels. McKinsey & Company research suggests that, by 2035, more than 50% of global power generation will come from renewable sources. Spurred on by this transition, demand for reliable energy storage systems is expected to attain exponential growth in the coming years, positively influencing the energy storage industry landscape, according to Grand View Research. Data from Fortune Business Insights projects that the global battery energy storage market will reach $19.74 billion by 2027, recording a CAGR of 20.4% from 2020 to 2027. The research firm suggests that improving access to electricity across the globe will be a prominent trend shaping the growth trajectory of this market, which is particularly noteworthy for StorEn and its TITANstack™ grid-scale energy storage solution. Over a billion people still do not have access to electricity. The electrification of these unserved communities can become a reality with mini grids, using solar plus energy storage. StorEn’s vanadium flow batteries could be a key technology toward providing universal access to affordable, longer lasting and dependable energy. In support this critical mission, StorEn Technologies is a member of the Alliance for Rural Electrification and the Global Off-Grid Lighting Association. Management Team StorEn is led by an executive team with decades of experience in the vanadium flow battery industry. Founder Carlo Brovero has served as the company’s chief executive officer, treasurer and director since its inception in January 2017. From 2013 to 2019, Mr. Brovero served as a consultant for eCaral Ltd., a management consulting firm. From 2013 to 2015, he served as an advisory board member for Proxhima S.r.l., a vanadium flow battery company, which was sold to the Gala Group, a utility listed on the Milan Stock Exchange. From 2010 to 2016, Mr. Brovero served as International Sales and Marketing Director for iVis Technologies, the manufacturer of an excimer laser therapeutic and refractive platform for corneal surgery. He holds an MBA from Aston University in Birmingham, UK. Founder Angelo D’Anzi has served as StorEn’s chief technology officer and director since the company’s inception. He is primarily responsible for the technical development of StorEn’s products. Since May 2018, Mr. D’Anzi has also served as a director of Arco Fuel Cells S.r.l., where he is responsible for the company’s fuel cell technical development activities. Mr. D’Anzi co-founded vanadium flow battery company Proxhima in 2013. In 2000, he founded ROEN-EST, a fuel cell company that was eventually acquired by the Morphic Group, a cleantech holding company listed on the Stockholm Stock Exchange. Mr. D’Anzi holds 14 international patents and received the 2003 Sapio Award in the Energy and Transportation category. He holds an MBA from the LUISS Business School in Rome. Founder Gabriele Colombo has served as secretary of StorEn since its inception. Since 2012, he has also served in various roles ranging from regional manager to CEO with Leonardo Hispania S.A., a subsidiary of the Leonardo Group of Italy, an aerospace, defense and security conglomerate. Mr. Colombo co-founded vanadium flow battery company Proxhima in 2013. He holds an honors degree in computer engineering from the University of Pisa and a master’s degree in business leadership from the University of Genova. For more information, visit the company’s website at www.StorEn.tech. NOTE TO INVESTORS: The latest news and updates relating to StorEn Technologies are available in the company’s newsroom at https://ibn.fm/StorEn

• Bladder cancer is still the sixth most prevalent cancer in the U.S. in 2021
• The total number of new bladder cancer cases is expected to reach 83,730, with deaths totaling 17,200 this year
• Imagin Medical Inc. is hoping to offer a better standard of care for bladder cancer patients with its i/Blue Imaging System(TM) that improves visualization for resection, potentially lowering recurrence rates

According to American Cancer Society statistics, the number of cases of all types of cancer this year will total almost 1.9 million, with 608,570 deaths, or approximately 5,200 new cases and 1,670 deaths per day (https://ibn.fm/eDdCz). Of those numbers, bladder cancer remains the sixth most prevalent form of cancer in the United States, with an estimated 83,730 (4.4% of total) new cases and 17,200 (2.8% of total) estimated deaths in 2021 and a greater than 50% recurrence rate. The five-year relative survival rate (2010-2016) was reported at 77% – meaning that only 77% of diagnosed patients survived five years after diagnosis (https://ibn.fm/Y9NoK).

One company, Imagin Medical (CSE: IME) (OTCQB: IMEXF), is looking to disrupt the industry, changing how cystoscopies for bladder cancer are performed, with the goal of potentially lowering recurrence rates and ultimately helping improve patients’ lives and long-term outlook. The company’s i/Blue Imaging System(TM) is a breakthrough cancer visualization technology currently in the manufacturing stage with Lighthouse Imaging, an FDA registered and ISO 13485:2016 certified contract manufacturer located in Maine. The project is on track for completion in 2022 (https://ibn.fm/q6YMg).

When patients present with symptoms that may be consistent with bladder cancer or other urinary-related conditions, the first step may be to perform a cystoscopy. The first symptom most commonly associated with bladder cancer is hematuria or blood in the urine. When coupled with other symptoms, doctors will perform further evaluations. These additional symptoms may include, but are not limited to:

• A need to urinate that is more frequent than usual
• Pain or burning during urination
• Feeling as if you need to urinate, or an increased urgency to urinate, even without a full bladder
• Having trouble urinating or a weak urine stream
• Needing to urinate many times during the night

For decades, cystoscopies have traditionally used white light illumination for visualization within the bladder. With this white light system, surgeons can visualize the bladder wall and detect and resect any protrusions or correct any inconsistencies, if necessary. However, flat tumors that do not protrude above the wall of the bladder cannot be visualized with white light alone, making it very difficult to perform a complete resection.

The introduction of blue light cystoscopies in 2010 has helped address this issue. Blue light cystoscopies use an FDA-approved contrast agent inserted into the bladder about an hour before the procedure. Once exposed to the blue light, the agent causes the cancerous cells to fluoresce, providing clear images of flat tumors and the margins. Blue light cystoscopy isn’t without its limitations – the current model on the market requires the surgeon or urologist to change views from white to blue light images to operate because the blue light image is not in real time and neither image provides proper orientation of the cancer within the bladder during resection. In addition, the cost of the current method is high and requires the purchase of proprietary, blue filtered cystoscopes that cannot be used for any other purpose.

Imagin Medical’s i/Blue Imaging System has the potential to revolutionize current cystoscopies by showing both white light and blue light images simultaneously side-by-side on the screen in real time, providing clear visualization of the fluoresced flat cancer cells and margins, in context within the bladder. This capability eliminates surgeons’ need to change between images and can potentially lead to lower recurrence rates and help assure a better standard of care and future for bladder cancer patients. In addition, the i/Blue System will come at an overall lower system cost and, because it will adapt to most endoscopes on the market, will allow hospitals and doctor’s offices to make use of scopes they already own, adding to the savings.

For more information, visit the company’s website at www.ImaginMedical.com.

NOTE TO INVESTORS: The latest news and updates relating to IMEXF are available in the company’s newsroom at https://ibn.fm/IMEXF

• As cultural institutions are closing down because of the pandemic, they are facing an increased security threat, as reduced staffing made them more vulnerable to thieves
• The issue was brought to the forefront after Singer Lauren museum in The Netherlands became the victim of a “smash-and-grab” theft of a priceless piece, The Parsonage Garden at Nuenen in Spring 1884, by Vincent van Gogh
• Knightscope’s technology can successfully increase security in multiple venues, including museums, libraries, galleries, and other cultural institutions
• The company’s autonomous security robot (“ASR”) offering includes K1 (stationary and provides temperature monitoring), K3 (indoor machine), and K5 (outdoor machine), all capable of being implemented into a museum setting

The COVID-19 pandemic is responsible for the temporary closure of approximately 90% of the world’s museums. According to research by UNESCO and the International Council of Museums, this percentage represents approximately 85,000 museums, 13% of which may never reopen. One alarming part of the equation is that due to the closures, the workforces of museums, libraries, galleries, and other cultural institutions that are in charge of these valuable pieces have found themselves at a reduced capacity. These low operational numbers leave such institutions vulnerable from a security standpoint and give thieves the confidence boost they need to make attempts on these valuables (https://ibn.fm/9jzIX). The recent theft of Vincent van Gogh’s The Parsonage Garden at Nuenen in Spring 1884 from Singer Lauren in the Netherlands highlights this issue, raising concern about the threat level to other museums worldwide. The Singer Lauren robbery in March 2020 garnered the attention of museum security staff and directors and resulted in increased monitoring measures and the implementation of 24-hour security operations. Even with the additional measures, however, thieves may still target these institutions, thinking they are in a weakened state because of reduced staffing during the pandemic. Advanced security technology company Knightscope, may be the solution that these institutions are missing to maintain security at all times. Founded in 2013 and based in Mountain View, California, Knightscope is a leader in developing autonomous security capabilities. The company is on target to disrupt the $500 billion security industry through its innovative technology that uniquely combines self-driving technology, robotics, and artificial intelligence (“AI”). Knightscope designs and builds Autonomous Security Robots (“ASRs”) that provide 24/7/365 security to the grounds it patrols, including places where consumers live, work, visit, and study. These ASRs have even assisted in the arrest of suspects involved in crimes that range from armed robbery to hit-and-runs. Implementing one of the Knightscope ASR designs in a museum, library, gallery, or another cultural institution is part of the very foundation of the ASRs’ designs, and could significantly help enhance security on these properties all while maintaining pandemic-imposed staffing restrictions. Knightscope’s current offering consists of K1 (stationary machine), K3 (indoor machine), and K5 (outdoor machine). The company has eight patents alongside a framework of intellectual property. The autonomous ASRs patrol client sites without remote control and provide a visible, force-multiplying, physical security presence. This presence is beneficial in protecting assets (like priceless paintings), monitoring for any physical changes within the patrol area, and the deterrence of crime. The data collected is accessible through the Knightscope Security Operations Center (“KSOC”). This intuitive and browser-based interface allows for security officials to review events monitored by the ASRs. All ASRs and technology associated with the Knightscope name are developed from the ground up and made in the USA. When cultural facilities reopen their doors to the public, implementation of Knightscope’s K1 unit can help with monitoring elevated body temperature (“EBT”), providing private alerts, and mitigating potential exposure. Not only can the assets be kept safe, but so can the patrons inside. Knightscope’s technology is on the forefront of helping America reopen safely for both staff members and the general public. For more information, visit the company’s website at www.Knightscope.com and if you have a need for subscription service you may request a private demonstration of the technology at www.Knightscope.com/demo. NOTE TO INVESTORS: The latest news and updates relating to Knightscope are available in the company’s newsroom at https://ibn.fm/Knight

• Nextech AR released its Q1 2021 financial and operating results after the markets closed on May 12, in line with an earlier commitment
• The company subsequently hosted a conference call in which the CEO and CFO discussed the results and responded to questions
• A recording of this live presentation will be available on Nextech’s website
• Nextech recently announced a partnership with Concordia University and CUCCIO to host the first-ever virtual Canadian Higher Education Information Technology (“CANHEIT”) conference

In an earlier communication, Nextech AR Solutions (CSE: NTAR) (OTCQB: NEXCF) had intimated that it would release its audited financial results on or around May 13. In line with this position, the company announced its first quarter 2021 financial results after markets closed on Wednesday, May 12, 2021. Providing the crucial facts and resources needed by analysts and investors, Nextech subsequently hosted a conference call in which CEO Evan Gappelberg and Chief Financial Officer Kashif Malik discussed these financial and operating results, and fielded questions during a scheduled Q&A session. To cater to those who were unable to join the live event, Nextech is making available on its website a recording of this earnings call. As one of the leaders in the rapidly growing augmented reality (“AR”) industry, Nextech is focused on creating an AR ecosystem that can be used in advertising, video conferencing, e-commerce, education, and training. Basing its operations on this focus, NTAR has offered its services to multiple companies and organizations such as TEDx, Vulcan Inc., Arch Insurance, UNESCO, Amazon (NASDAQ: AMZN), Bell Canada (NYSE: BCE), Dell Technologies (NYSE: DELL), Viacom (NASDAQ: VIAC), Johnson and Johnson (NYSE: JNJ) and more. The company recently added a new entry to this list of clients when it announced its Virtual Experience Platform (“VXP”) has been selected to host this year’s virtual Canadian Higher Education Information and Technology Conference (“CANHEIT”) to be held May 31-June 4 (https://ibn.fm/91XE6). CANHEIT is a national conference for IT professionals in higher education, including staff, managers and senior administrators, mandated with the management and advancement of their institutions’ digital infrastructure, as well as information and learning systems. During the conference, to be hosted in partnership with Concordia University and CUCCIO, these professionals will showcase best practices and collaborate. This year’s CANHEIT will be one of a kind because, in addition to being the first-ever virtual event in the conference’s history – a departure from the traditional in-person event practice – Nextech is committed to making it memorable and immersive through its VXP platform. This platform will enable attendees to access interactive virtual networking spaces, a virtual exhibitor hall with 30-40 chat-enabled exhibitor booths and breakout rooms. Additionally, being an AR technology provider, Nextech will offer attendees an AR experience through AR portals available on the VXP platform, which will enable them to enter a virtual world and subsequently experience Concordia University as if they were there in person. “It’s been a fantastic experience organizing the first-ever virtual CANHEIT conference with a company like Nextech,” commented Associate Vice President and CIO of Concordia University France Bigras. “As we continue to adapt to an ever-changing world of virtual learning and interactivity, it was important for us to select a robust all-in-one solution to host our premier event and provide attendees and sponsors alike with a truly unique experience.” Nextech takes pride in the fact that its VXP platform has exceptional AR/VR capabilities that, when combined with its comprehensive objective of creating novel and exciting ways of bringing global communities together, have enabled it to support numerous virtual and hybrid conferences and events. The company is committed to offering an immersive experience for event attendees, thereby bridging the gap between the physical and digital world. For more information, visit the company’s website at www.NextechAR.com. NOTE TO INVESTORS: The latest news and updates relating to NEXCF are available in the company’s newsroom at https://ibn.fm/NEXCF

• Company announces renegotiation of $4.2 million of convertible notes
• Report shows net revenues of $3,672,353 for the year ended Dec. 31, 2020, an increase of $3,221,157 over 2010 revenues
• GPFT looks forward to growing distribution business, ushering in the age of Hourglass

After spending the last six weeks renegotiating key terms of an estimated $4.2 million of convertible notes, Grapefruit USA (OTCQB: GPFT) announced its financial results for fiscal year 2020, the period ended Dec. 31, 2020 (https://ibn.fm/ZxUxa). In addition to the restructure of the convertible debt, a highlight of the report in was the company’s 714% year-over-year revenue growth. “We are pleased to report net revenues of $3,672,353 for the year ended Dec. 31, 2020, an increase of $3,221,157 or 714% over revenues of $451,196 for the year ended Dec. 31, 2019, despite operating during a global pandemic,” said Grapefruit CEO Brad Yourist. “We are also heartened to report that over the last several weeks we have been engaged in an exercise in holding the line for our company and its loyal shareholder base with respect to renegotiating the notes with our institutional investor. We think we have achieved a very positive result and look forward to continuing to grow our distribution business and to fully usher in the age of Hourglass, our remarkable cannabinoid hemp-based CBD and THC topical time release delivery system.” According to the announcement, Grapefruit began renegotiating the terms of the notes after an audit showed that the notes contained a variable conversion price feature that would force in the company to recognize a noncash loss in excess of $40 million for FY2020. Discussions between company management and the company investor resulted in an agreement to modify the notes, thus eliminating the variable conversion price feature. As a result of the modifications, an estimated $40 million noncash loss for the year 2020 was eliminated; complete details of the agreement are available in Grapefruit’s annual report (https://ibn.fm/1iVes). “We look forward to more success in 2021, which is already off to a superb start and will shift into high gear in the next few days with Grapefruit’s live launch of its retail hemp-derived CBD products website featuring our disruptive hemp CBD based Hourglass products,” said Yourist. “In addition, we have been informed by our Canadian joint venture/potential acquisition group that their shareholder’s meeting will be held this week as previously reported and at the conclusion of which our discussions will restart immediately. Further updates with respect to the new Grapefruit hemp-based CBD Hourglass retail website live launch and Canadian JV/acquisition progress will be provided in real time.” Hourglass is a patented, disruptive gamechanger in the recreational and medicinal cannabis and CBD market. Grapefruit is devoted to selling only high-quality, laboratory tested, and reliable products. All of Grapefruit’s hemp CBD-based products to be marketed and sold on the new e-commerce website will be tested and come with a QR coded Certificate of Analysis, which provides consumers with certified precise and accurate labeling of the product’s cannabinoid content, purity, and safety. To find out more about the company and its game-changing Hourglass time-release cannabinoid delivery cream, please visit  www.GrapefruitBlvd.com. NOTE TO INVESTORS: The latest news and updates relating to GPFT are available in the company’s newsroom at https://ibn.fm/GPFT

• Orphan-stage pharmaceutical innovator Tryp Therapeutics is dedicated to developing novel therapies for medical conditions with unmet needs
• Tryp’s embrace of psychedelic drug potential is demonstrated in its advancing clinical trials seeking an answer to eating disorders such as binge eating and hyperphagia
• The company is also developing a clinical trial to address the needs of fibromyalgia patients who often rely on opioids to relieve their symptoms
• Tryp has announced two new collaborations for oversight of the drug trials this month; consultants with Fluence and Clinlogix will help to ensure the quality of the tests

Bioscience pharmaceutical company Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), pursuing its goal of developing psychedelic drug treatments for diseases that otherwise have unmet medical needs, is continuing to prepare for an upcoming Phase 2a clinical trial for treating eating disorders by forging partnerships with professionals experienced in conducting such trials.

The company’s recent announcement that it will collaborate with psychedelic therapy educational platform Fluence in a master service agreement to provide design and training for the psychotherapeutic portion of the upcoming trials follows on the heels of Tryp’s agreement with the University of Florida to conduct the clinical trial.

Pediatric medical researcher Jennifer Miller, M.D., of the University of Florida is leading the investigation into the potential of Tryp’s TRP-8802 psilocybin product for safety, pharmacokinetics and efficacy. Miller is an expert in certain eating disorders including binge eating and hyperphagia.

“There are currently no approved drugs and only limited options to treat patients with rare over-eating disorders,” Miller stated in a news release announcing the collaboration (https://ibn.fm/rSnYK).

The company’s upcoming Phase 2a trial for fibromyalgia patients is designed to provide an alternative treatment option for the large number of patients currently relying on opioids to relieve their symptoms.

Fluence is led by researchers and psychotherapists with direct experience in conducting psychedelic clinical trials and is the foremost provider of psychotherapeutic training for health professionals that are administering psychedelic compounds to patients, according to another news release issued May 3 (https://ibn.fm/SO55k).

“In the fast-moving arena of psychedelic therapies, Fluence has established themselves as the leader in psychotherapy design and training,” Tryp President and Chief Science Officer Jim Gilligan stated in the news release. “Psychotherapy is an essential component of the effective administration of our innovative psilocybin formulations for the chronic pain and eating disorder indications that we are pursuing. Fluence’s experience with training hundreds of clinicians combined with the training protocol they are creating with Tryp will help create a safer and more effective treatment protocol for our clinical trials and ultimately for patients suffering from these conditions.”

Additionally, Tryp announced May 10 that Contract Research Organization (“CRO”) Clinlogix will provide support services for the upcoming Phase 2a trials (https://ibn.fm/V0Zr7). Clinlogix has developed experience in providing CRO services for the development of novel pharmaceutical products on a global basis, and the master service agreement between Tryp and Clinlogix will support the development of Tryp’s Psilocybin-for-Neuropsychiatric Disorders (“PFNTM”) program, according to the announcement.

“The proper execution of a clinical study is of paramount importance in order to achieve clinical success; working with the team from Clinlogix provides Tryp with key elements needed for the conduct of a successful clinical study,” Gilligan added.

For more information, visit the company’s website at www.TrypTherapeutics.com.

NOTE TO INVESTORS: The latest news and updates relating to TRYPF are available in the company’s newsroom at https://ibn.fm/TRYPF

 

• SRAX Inc. will host conference call to announce Q1 2021 results on May 17, 2021
• Call will be hosted via live video call, will also feature question & answer session
• SRAX released Q4 2020 results earlier this year, revealing 316% YoY increase in revenues, upping its 2021 sales guidance to $23-25 million

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, is scheduled to host a conference call to discuss its Q1 2021 results on May 17th, 2021. The call will feature SRAX Founder and CEO Christopher Miglino as well as SRAX CFO Michael Malone, who will provide investors with an operational and financial summary of their quarterly earnings on a live video call, along with hosting a question-and-answer session, on May 17, 2021 at 1:30 pm PT/4:30 pm ET (https://ibn.fm/wHuuS).

SRAX has seen its financial returns go from strength to strength over the past year. Earlier this year the Company released its Q4 2020 results (https://ibn.fm/rP4Mm). At the time the Company reported Q4 revenues of $4.5 million, up 316% year-over-year whilst simultaneously reporting Q4 net income of $200,000, a significant increase relative to the net loss of -$4.4 million witnessed in Q4 of 2019.

SRAX also seized upon the opportunity to raise its FY2021 revenue guidance to $23-25 million, a substantial increase from its previous guidance of $17-18 million, implying a growth rate of between 164-187% year-over-year for FY2021.

SRAX also provided an update on Sequire at the time, revealing that the investor intelligence platform had secured bookings of $4.8 million and $10 million for the fourth quarter of 2020 and first quarter of 2021, respectively, whilst also seeing its corporate subscriber base swell to 183 publicly listed companies (versus 92 companies as of their Q3 2020 update). SRAX also announced that Sequire would recognize $16.5 million in revenues based on its existing contracts over the course of the 2021 fiscal year.

“We are making great progress with our platform and we are seeing continued adoption of the products that we are building for issuers,” stated SRAX CEO Christopher Miglino following the Company’s Q4 2020 results. “We had another record quarter of bookings for Sequire. In the first quarter of 2021 we have closed over $10 million in contracts.”

SRAX has taken several steps to augment and streamline its operations over the past few months, including naming entrepreneur and 2020 presidential candidate Brock Pierce to the Company’s board of directors, divesting an equity stake in TI Health (formerly known as SRAXmd), and announcing a substantial line-up of investor conferences to be held via the Sequire platform over the coming year.

With Sequire’s popularity rising to new heights among both corporate issuers and investors alike, SRAX stands well poised to benefit from its success.

To register for the live webcast and view the presentation, please sign up at the following link: https://Q12021earningscall.mysequire.com.

Investors who would like to access the earnings call by phone can use the following details:

Phone Number: +1 669-900-6833 | Webinar ID: 959-8207-6042 | Passcode: 288501

For more information, visit the company’s website at www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX